Home
About
FAQ
History (5)
Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.
An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.
Diabetes status modifies the association between carotid intima-media thickness and incident heart failure: The Atherosclerosis Risk in Communities study.
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.
Haro MA, Dyevoich AM, Phipps JP, Haas KM. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity. Cancer Res. 2019 01 01; 79(1):159-170.
View in:
PubMed
subject areas
Animals
B-Lymphocyte Subsets
Cord Factors
Female
Immunity, Innate
Immunoglobulin M
Lectins, C-Type
Lipid A
Lymphocyte Activation
Male
Mammary Neoplasms, Animal
Mice
Mice, Inbred A
Mice, Inbred C57BL
Peritoneal Cavity
Peritoneal Neoplasms
Toll-Like Receptors
authors with profiles
Karen M. Haas PhD